8 Bold Moves General Motors Could Make to Rev Up Its Battered Stock Price
Amidst all the attention on Tesla's (TSLA) struggles and insanely volatile stock this year, the share price under-performance of profitable automaker General Motors (GM) has gone overlooked. And it's time management does something about it. &nbs...Read More>>>
This Is Your 2013 Potential Bitcoin Profit Opportunity All Over Again
Back in July 2013, Money Morning Defense and Tech Specialist Michael A. Robinson went on live television with a bold prediction for Bitcoin (BTC).
His first cryptocurrency summit in 2013 laid out simple strategies that could've netted phenom...Read More>>>
The Money Calendar Can Show You How to Profit in a Matter of Seconds
Traders frequently turn to earnings reports for quick profits thanks to the potential of a stock to pop – or bust – after an earnings call. But you don't need to wait for an earnings report to find stocks about to move.
The reali...Read More>>>
10 Most Affordable Cities for Fastest Growing Careers
The U.S. economy is rocking along right now, growing at a rate of around 3% a year. An unemployment rate of around 4% means that most Americans who want jobs can find one.
But what if you are looking to change careers and are investing time and money...Read More>>>
DACA students fear tuition ruling will force them to drop out of college
Gilbert Olmos should be excited that he's wrapping up his freshman year at South Mountain Community College and getting one step closer to his dream of becoming a registered nurse. But instead he's terrified his college education -- and his dream --...Read More>>>
PowerShares Dynamic Healthcare Sector Portfolio (the Fund) seeks investment results that correspond generally to the price and yield of the Dynamic Healthcare Sector Intellidex Index (the Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Index thoroughly evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investments and risk factors. Securities shown to possess the greatest capital appreciation potential are selected by the Index.The Fund invests only in health care sector. The Fund’s investment advisor is PowerShares Capital Management LLC.
Draegerwerk AG & Co KGaA is a Germany-based provider of medical and safety technology. The Company operates through two segments: Medical and Safety. The Medical segment develops, produces and markets system solutions, equipment and services for the optimization of processes at the acute point of care, such as emergency care, preoperative care, critical care and prenatal care. The Safety segment develops, produces and markets products, system solutions and services for personal protection, gas detection technology and integrated hazard management for customers from various industries, such as mining, fire departments, police and disaster protection. The Company has production sites in Europe, the Americas, Africa and Asia.
Wells Fargo & Company is a bank holding company. The Company is a diversified financial services company. It has three operating segments: Community Banking, Wholesale Banking, and Wealth and Investment Management. The Company offers its services under three categories: personal, small business and commercial. It provides retail, commercial and corporate banking services through banking locations and offices, the Internet and other distribution channels to individuals, businesses and institutions in all 50 states, the District of Columbia and in other countries. It provides other financial services through its subsidiaries engaged in various businesses, including wholesale banking, mortgage banking, consumer finance, equipment leasing, agricultural finance, commercial finance, securities brokerage and investment banking, computer and data processing services, investment advisory services, mortgage-backed securities servicing and venture capital investment.
Dimension Therapeutics, Inc. is a gene therapy company. The Company is focused on discovering and developing therapeutic products for people living with rare diseases associated with the liver and caused by genetic mutations. It has programs for hemophilia B, hemophilia A, ornithine transcarbamylase (OTC) deficiency, and glycogen storage disease type Ia (GSDIa). The Company’s gene therapy product candidates and programs are designed to provide a functional copy of an abnormal or missing gene using the advanced adeno-associated virus (AAV)-based vector delivery technology. DTX101 is the Company’s lead gene therapy product candidate designed to deliver Factor IX (FIX), gene expression in patients with hemophilia B. DTX201 is its Factor VIII (FVIII) gene therapy program for the treatment of hemophilia A. DTX301 is its gene therapy product candidate designed for the treatment of patients with OTC deficiency. DTX401 is its gene therapy program for the treatment of patients with GSDIa.
KapStone Paper and Packaging Corporation was formed in Delaware as a special
purpose acquisition corporation on April 15, 2005 for the purpose of effecting a
merger, capital stock exchange, asset acquisition or other similar business
combination with an unidentified operating business in the paper, packaging,
forest products, and related industries. Unless the context otherwise requires,
references to “KapStone,” the “Company,” “we,” “us” and “our” refer to KapStone
Paper and Packaging Corporation and its subsidiaries.